Endorsements by Michele Avissar-Whiting

0000-0003-0030-3135

Program Officer | Open Science Strategy, Howard Hughes Medical Institute
Editor in Chief, Research Square
PhD, Brown University

Endorsements

Building trust in preprints: recommendations for servers and other stakeholders
robustclear
All endorsers

Own works

Recommendations for accelerating open preprint peer review to improve the culture of science.
All endorsers
Advancing the culture of peer review with preprints
All endorsers
Ten Simple Rules for Post-Pandemic Preprinting
All endorsers
Downstream retraction of preprinted research in the life and medical sciences
All endorsers
Downstream retraction of preprinted research in the life and medical sciences
All endorsers
PReF: describing key Preprint Review Features
All endorsers
Addressing disorder in scholarly communication: Strategies from NISO Plus 2021
All endorsers
Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero.
All endorsers
Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma.
All endorsers
Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta.
All endorsers
Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer.
All endorsers
Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta.
All endorsers
Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.
All endorsers
Bisphenol A exposure leads to specific microRNA alterations in placental cells.
All endorsers
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.
All endorsers
A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
All endorsers
MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma.
All endorsers